NovoLog FlexPen U-100 (100 units/mL) FlexPen Images
Generic Name: insulin aspart
This medication has been identified as NovoLog FlexPen U-100 (100 units/mL) FlexPen. It is supplied by Novo Nordisk.
NovoLog FlexPen is used in the treatment of Diabetes, Type 2; Diabetes, Type 1; Diabetic Ketoacidosis; Nonketotic Hyperosmolar Syndrome and belongs to the drug class insulin. There is no proven risk in humans during pregnancy. NovoLog FlexPen U-100 (100 units/mL) FlexPen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
NovoLog FlexPen
- Generic Name
- insulin aspart
- Strength
- U-100 (100 units/mL) FlexPen
- Availability
- Prescription only
- Drug Class
- Insulin
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novo Nordisk
- National Drug Code (NDC)
- 00169-6339
More about NovoLog FlexPen (insulin aspart)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: insulin
- En español
Patient resources
Other brands
Professional resources
Other brands
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
